Cargando…
Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782751/ https://www.ncbi.nlm.nih.gov/pubmed/35111852 http://dx.doi.org/10.18502/jad.v15i2.7483 |
_version_ | 1784638379906826240 |
---|---|
author | Razavi, Mohamad Reza Shirzadi, Mohammad Reza Mohebali, Mehdi Yaghoobi-Ershadi, Mohammad Reza Vatandoost, Hassan Shirzadi, Mehrshad Gouya, Mohammad Mehdi Gharachorloo, Faranak Arshi, Shahnam Amiri, Behzad |
author_facet | Razavi, Mohamad Reza Shirzadi, Mohammad Reza Mohebali, Mehdi Yaghoobi-Ershadi, Mohammad Reza Vatandoost, Hassan Shirzadi, Mehrshad Gouya, Mohammad Mehdi Gharachorloo, Faranak Arshi, Shahnam Amiri, Behzad |
author_sort | Razavi, Mohamad Reza |
collection | PubMed |
description | Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance system in 2019, and evaluated in Center for Communicable Diseases Management in Ministry of Health in Iran. Iran has been considered an endemic area for cutaneous leishmaniasis in the world. Dependent to activities for cutaneous leishmaniasis control the number of cases decreased from 23202 in 2008 (Incidence rate 32 per 100000) to 13124 in 2019 (Incidence rate 15.8 per 100000), more cases reported from September to December, in 2019, 46% of cases had one lesion and 21% had 2 lesions, 85% of cases diagnosed when the diameter of lesions had 3 centimeters and bellows. Although the Leishmania control program began in 1977, the incidence of the disease has dropped dramatically since 2008 when the new cutaneous leishmaniasis control program have been implemented. Although in some areas the incidence of the disease increased, but the implementation of the new program has reduced the number of cases, in order to continue reducing the disease, permanent support for the control programs is needed. |
format | Online Article Text |
id | pubmed-8782751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-87827512022-02-01 Human Cutaneous Leishmaniosis in Iran, Up to Date-2019 Razavi, Mohamad Reza Shirzadi, Mohammad Reza Mohebali, Mehdi Yaghoobi-Ershadi, Mohammad Reza Vatandoost, Hassan Shirzadi, Mehrshad Gouya, Mohammad Mehdi Gharachorloo, Faranak Arshi, Shahnam Amiri, Behzad J Arthropod Borne Dis Review Article Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance system in 2019, and evaluated in Center for Communicable Diseases Management in Ministry of Health in Iran. Iran has been considered an endemic area for cutaneous leishmaniasis in the world. Dependent to activities for cutaneous leishmaniasis control the number of cases decreased from 23202 in 2008 (Incidence rate 32 per 100000) to 13124 in 2019 (Incidence rate 15.8 per 100000), more cases reported from September to December, in 2019, 46% of cases had one lesion and 21% had 2 lesions, 85% of cases diagnosed when the diameter of lesions had 3 centimeters and bellows. Although the Leishmania control program began in 1977, the incidence of the disease has dropped dramatically since 2008 when the new cutaneous leishmaniasis control program have been implemented. Although in some areas the incidence of the disease increased, but the implementation of the new program has reduced the number of cases, in order to continue reducing the disease, permanent support for the control programs is needed. Tehran University of Medical Sciences 2021-06-30 /pmc/articles/PMC8782751/ /pubmed/35111852 http://dx.doi.org/10.18502/jad.v15i2.7483 Text en Copyright © 2021 The Authors. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
spellingShingle | Review Article Razavi, Mohamad Reza Shirzadi, Mohammad Reza Mohebali, Mehdi Yaghoobi-Ershadi, Mohammad Reza Vatandoost, Hassan Shirzadi, Mehrshad Gouya, Mohammad Mehdi Gharachorloo, Faranak Arshi, Shahnam Amiri, Behzad Human Cutaneous Leishmaniosis in Iran, Up to Date-2019 |
title | Human Cutaneous Leishmaniosis in Iran, Up to Date-2019 |
title_full | Human Cutaneous Leishmaniosis in Iran, Up to Date-2019 |
title_fullStr | Human Cutaneous Leishmaniosis in Iran, Up to Date-2019 |
title_full_unstemmed | Human Cutaneous Leishmaniosis in Iran, Up to Date-2019 |
title_short | Human Cutaneous Leishmaniosis in Iran, Up to Date-2019 |
title_sort | human cutaneous leishmaniosis in iran, up to date-2019 |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782751/ https://www.ncbi.nlm.nih.gov/pubmed/35111852 http://dx.doi.org/10.18502/jad.v15i2.7483 |
work_keys_str_mv | AT razavimohamadreza humancutaneousleishmaniosisiniranuptodate2019 AT shirzadimohammadreza humancutaneousleishmaniosisiniranuptodate2019 AT mohebalimehdi humancutaneousleishmaniosisiniranuptodate2019 AT yaghoobiershadimohammadreza humancutaneousleishmaniosisiniranuptodate2019 AT vatandoosthassan humancutaneousleishmaniosisiniranuptodate2019 AT shirzadimehrshad humancutaneousleishmaniosisiniranuptodate2019 AT gouyamohammadmehdi humancutaneousleishmaniosisiniranuptodate2019 AT gharachorloofaranak humancutaneousleishmaniosisiniranuptodate2019 AT arshishahnam humancutaneousleishmaniosisiniranuptodate2019 AT amiribehzad humancutaneousleishmaniosisiniranuptodate2019 |